ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Yasons Chemex's subsidiary Rishit Polysurf LLP signed a slump sale agreement to sell its chemical manufacturing business to Vasudha Specialities Emulsifiers. Consideration is Rs.29.61 Crore in cash.
Yasons Chemex Care Ltd reported revenue from operations of ₹41.2 Cr (-16.4% YoY) and net profit of ₹1 Cr (+0.0% YoY) for H1 FY27.
Yasons Chemex Care filed a non-applicability certificate for Corporate Governance provisions for Q1 FY27. Its exclusive NSE EMERGE listing exempts it from those requirements.
Yasons Chemex Care Limited appointed Mr. Krunal Tilakkumar Thakkar as Company Secretary and Compliance Officer. He joins as a Key Managerial Personnel effective October 1, 2026.
Yasons Chemex Care Limited conducted its 9th Annual General Meeting on September 30, 2026, transacting various ordinary and special business items.
Yasons Chemex Care will hold its 9th AGM on 30 September 2026. Remote e-voting opens 27 September.
Yasons Chemex Care Limited appointed M/s. N. H. Desai & Co. as Internal Auditor for a 12-month term. The appointment was approved during a board meeting on August 26, 2026.
Yasons Chemex Care Limited's board approved the appointment of M/s N. H. Desai & Co. as Internal Auditors. The board also convened its 9th AGM for September 2026.
Yasons Chemex Care Limited clarified that it has now submitted the corrected financial results and audit reports for the half-year ended 31st March 2026.
Ms. Riddhi Sumit Shah resigned as Company Secretary and Compliance Officer of Yasons Chemex Care. Her resignation is effective from the close of business hours on July 15, 2026.
Yasons Chemex Care approved its audited standalone and consolidated financial results. Results cover the half year and year ended March 31, 2026.
Yasons Chemex Care Limited reported zero deviation in utilizing ₹20.57 Crore raised through public issues. Funds were deployed for working capital and corporate purposes.
Yasons Chemex Care Ltd reported revenue from operations of ₹47.5 Cr (+0.6% YoY) and a net loss of ₹0.1 Cr for H2 FY26.
Yasons Chemex Care reported standalone total income of ₹73.65 Crore for FY26. The board approved audited financial results with an unmodified auditor opinion.
Yasons Chemex Care scheduled a board meeting on May 29, 2026, to approve audited annual financial results. The trading window remains closed until May 31.
Yasons Chemex Care Limited submitted its Structured Digital Database compliance certificate for FY2026. The filing confirms adherence to SEBI insider trading regulations and data maintenance.
Yasons Chemex Care Limited confirmed it is not identified as a 'Large Corporate' as of March 31, 2026, under SEBI's debt-raising framework. Consequently, initial disclosure requirements for fund raising through issuance of debt securities are not applicable to the company for the specified period.
Yasons Chemex Care Limited submitted a certificate stating non-applicability of Corporate Governance provisions for the quarter and financial year ended March 31, 2026. As an SME-listed company on the NSE EMERGE platform, it is exempt under SEBI Regulation 15(2). The company will continue to comply with other applicable listing regulations.